Search Details

Word: virologist (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...have so richly deserved a Nobel Prize in medicine as Virologist Francis Peyton Rous, 87, of Manhattan's Rockefeller University, and Surgeon Charles Brenton Huggins, 65, of the University of Chicago. But each man seemed to have lost his chance long ago. It is more than 50 years since Rous did his pioneering cancer research, more than 25 since Huggins made his impressive contributions to treatment of the same disease. But last week Stockholm's Royal Caroline Institute belatedly corrected both glaring omissions. It named Drs. Rous and Huggins to share the 1966 Nobel Prize in physiology...

Author: /time Magazine | Title: Awards: Belated Recognition | 10/21/1966 | See Source »

Died. Dr. Richard E. Shope, 64, pioneer virologist, who in 38 years at the Rockefeller Institute was the first to isolate an influenza virus (1931) and the first to prove that a virus could cause cancer in rabbits (1932), scored two other feats by surviving a form of meningitis (caught from lab mice) rarely found in humans and by being one of the few to survive eastern equine encephalitis without brain damage; of cancer of the pancreas; in Manhattan...

Author: /time Magazine | Title: Milestones: Oct. 14, 1966 | 10/14/1966 | See Source »

...decade since Virologist Jonas Salk perfected his anti-polio vaccine, the disease has been all but wiped out in the U.S. Reported cases of paralytic polio have dramatically declined, from 18,000 cases in 1954 to a mere 94 last year; the chance of getting polio today is less than the risk of diphtheria, malaria or typhoid fever. Last week, on the tenth anniversary of the approval of the Salk vaccine for general use, congressional leaders presented Dr. Salk with a joint resolution of the Senate and House expressing the nation's gratitude. The U.S. Public Health Service...

Author: /time Magazine | Title: Research: No More Triumphs? | 4/23/1965 | See Source »

...announcement that Indianapolis' Pitman-Moore Division of the Dow Chemical Co. has now begun to market a one-shot vaccine that is expected to give lifelong immunity. The virus used in the new vaccine is derived from the famed Edmonston strain used by Harvard's Nobel-prizewinning Virologist John F. Enders (TIME Cover, Nov. 17, 1961), but new research has added many advantages. When the attenuated virus in Enders' vaccine remained strong enough to give the required immunity, it was also strong enough to give many children what amounted to a slight case of measles, with a mild rash...

Author: /time Magazine | Title: One-Shot Vaccine for Measles | 2/19/1965 | See Source »

...Christopher Andrewes has spent most of his virologist's life studying the ailment, and in a new book just published in London, The Common Cold (Weidenfeld and Nicolson; 25 s.), Andrewes sums up what is known about the disease. He concludes that even the name is dubious. "That it is common admits of no dispute. But why cold? Is it because we feel chilly when we have a cold or because chilling brings it on (or is supposed to do so) or because the infection is commoner during the cold time of the year...

Author: /time Magazine | Title: Infectious Diseases: The Still Common Cold | 2/12/1965 | See Source »

Previous | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | Next